KRAS and lung adenoma: Systemic delivery of LNA-anti-miR-21 combined with only two doses of cisplatin over 7 weeks in these mice completely abolished the onset of lung adenomas and hyperplasia, denoting that miR-21 plays a major role in KRAS-mediated lung tumorigenesis.